查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1602125

特种药品分销市场：按适应症、经销商类型、分销类型、最终用户分类 - 2025-2030 年全球预测

Specialty Drug Distribution Market by Disease Indication (AIDS, Hemophilia, Multiple Sclerosis), Distributor Type (Full line Wholesalers, Specialty Distributors), Distribution Type, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年专科药品分销市场规模为47.6亿美元，预计2024年将达到54.7亿美元，复合年增长率为14.44%，预计到2030年将达到122.5亿美元。

特殊药品流通市场主要涉及需要综合处理的特殊药品的供应和管理，例如高成本、需要特定储存和管理的药品。这些药物包括治疗癌症、爱滋病毒和多发性硬化症等慢性疾病，通常需要单独的通路。对个人化医疗的需求不断增长，以及对能够管理复杂物流并防止潜在瓶颈的创新输送系统的需求，强调了对特种药物分销的需求。透过应用，该市场透过高效、安全地提供所需药物来为药房、医院和诊所提供支持，同时患者也可以从确保最佳健康结果的专门治疗方法中受益。这种分配模式主要服务于医疗保健部门，并影响公共和私人组织。

主要市场统计
基准年[2023] 47.6亿美元
预测年份 [2024] 54.7亿美元
预测年份 [2030] 122.5亿美元
复合年增长率（%） 14.44%

区块链和物联网等创新技术正在使供应链更加安全和透明，生技药品和基因治疗的快速成长被认为是市场扩张的关键驱动力。强调以患者为中心的照护模式将扩大宅配服务和基于价值的安排的机会，从而提供新的成长机会。然而，监管复杂性、特种药物的高成本和报销问题等挑战可能会构成重大障碍并影响市场动态。农村地区有限的基础设施可能进一步阻碍有效的分配。

为了克服这些挑战，该行业必须投资数位健康平台和资料分析，以优化供应链并提高病人参与。低温运输物流和自动化的创新可以显着降低管理成本并提高配送效率。市场的本质是技术快速进步和严格的法规环境，因此需要积极采用新技术并促进相关人员之间的合作。促进配方和输送机制的创新，再加上与高科技公司的策略伙伴关係关係，将增强我们有效克服挑战的能力，并确保在特种药品分销市场上的永续性和竞争优势。

市场动态：揭示快速发展的专业药品分销市场的关键市场洞察

供需的动态交互作用正在改变专科药品分销市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 增加特种药物开发平臺和交易
    • 强调优化药品成本、供应和储存，以提供以病人为中心的护理
  • 市场限制因素
    • 管理各种分销管道的复杂性
  • 市场机会
    • 整合特种药物分销的新技术与进步
    • 在世界各地扩张专业药房
  • 市场挑战
    • 与专科药物相关的法规结构的变化

波特五力：驾驭特种药品经销市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解专业药品分销市场的外部影响

外部宏观环境因素在塑造专业药品分销市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解专科药品分销市场的竞争状况

对专业药品分销市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 专业药品分销市场供应商定位矩阵绩效评估

FPNV 定位矩阵是评估专业药品分销市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。四个象限清楚且准确地划分供应商，帮助使用者辨识最能满足其策略目标的合作伙伴和解决方案。

本报告提供了涵盖关键重点领域的全面市场分析：

1. 市场渗透率：对当前市场环境的详细回顾，包括行业主要企业的大量资料。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 增加特种药物开发平臺和交易
      • 专注于优化药品成本、供应和储存，提供以患者为中心的护理
    • 抑制因素
      • 管理各种分销管道的复杂性
    • 机会
      • 整合及推进特种药物分销新技术
      • 专业药局正在世界各地扩张
    • 任务
      • 与特殊药物处理相关的法规结构的变化
  • 市场区隔分析
    • 疾病适应症：治疗肿瘤疾病的专用药物需求增加
    • 经销商类型：特种药品的全线批发商日益增多
    • 分销形式：专科药局渗透率高
    • 最终用户：家庭环境中专业药品分配的新可能性
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 专科药品流通市场：依适应症分类

  • 爱滋病
  • 血友病
  • 多发性硬化症
  • 肿瘤学
  • 类风湿性关节炎

第七章 专业药品分销市场：经销商类型

  • 全线批发商
  • 专业经销商

第八章 专业药品分销市场：依分销类型

  • 医院/诊所药房
  • 独立药房
  • 大型连锁药房
  • 通讯药房
  • 网路商店
  • 专业药房

第九章 专业药品分销市场：依最终用户分类

  • 门诊手术中心
  • 医疗保健付款人
  • 主页设定
  • 医院/诊所

第十章美洲专业药品经销市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区特种药品分销市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲的特用药品分销市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • FFF Enterprises 宣布与 Verrica Pharmaceuticals 合作，成为 YCANTH 的独家经销商，YCANTH 是 FDA核准的第一种传染性软疣治疗药物
    • Orsini Specialty Pharmacy 已被选为 VEOPOZ (poselimab-BBFG) 的独家专业药房合作伙伴，VEOPOZ (poselimab-BBFG) 是第一个也是唯一一个治疗 CHAPLE 疾病的药物。
    • Medis 与 ESTEVE 在 10 个中东欧国家签署经销协议
    • 珠峰医药宣布与上海医药子公司达成策略联盟，加速XERAVA在中国当地的商业化
    • Elevance Health 宣布完成 Bioplus 收购
    • CVS Health 收购 Oak Street Health
    • Shields Health Solutions 与 MyMichigan Health 合作，加强为患者和家庭提供的专业药房服务
    • Seals Health Solutions 扩大全国伙伴关係关係以改善专业药房服务
    • Prime Therapeutics 完成以 13.5 亿美元收购 Magellan Rx，结合药学和药品管理专业知识
    • 加拿大麦克森推出新的数位生态系统，以简化和增强专业患者的治疗效果
    • 宏利和 Shoppers Drug Mart 联手帮助管理严重的医疗状况
    • Marken 同意收购 Cedra Express 的医疗宅配业务，扩大在新西兰的直接业务
    • 康德乐继续拓展家庭解决方案业务
    • Harozyme 将以约 9.6 亿美元收购 Antares Pharma

公司名单

  • Shanghai Pharmaceuticals Group Co., Ltd.
  • CVS Specialty, Inc. by CVS Health Corporation
  • AmerisourceBergen Corporation
  • China National Pharmaceutical Group Corporation
  • Teva Pharmaceutical Industries Ltd.
  • McKesson Corporation
  • Suzuken Co., Ltd.
  • Eversana
  • PHOENIX Pharmahandel GmbH & Co KG
  • Accredo Health Group, Inc.
  • Lifeline Pharmaceuticals, LLC
  • Aark Pharmaceuticals
  • Optum, Inc.
  • Feron Healthcare Pvt Ltd.
  • Morris & Dickson Co., LLC
  • Medipal Holdings Corporation
  • Kroger Specialty Pharmacy
  • Walmart Inc.
  • Elevance Health, Inc.
  • FFF Enterprises Inc.
  • Cardinal Health, Inc.
  • Shields Health Solutions Holdings, LLC
  • Medis Intago, doo
  • Marken by United Parcel Service, Inc.
  • Centene Corporation
  • Sun Pharmaceutical Industries Limited
  • BioCare, Inc.
Product Code: MRR-43192CEFCC35

The Specialty Drug Distribution Market was valued at USD 4.76 billion in 2023, expected to reach USD 5.47 billion in 2024, and is projected to grow at a CAGR of 14.44%, to USD 12.25 billion by 2030.

The specialty drug distribution market primarily involves the supply and management of specialized pharmaceuticals that require comprehensive handling, including drugs with high costs and specific storage or administration needs. These include treatments for chronic diseases such as cancer, HIV, and multiple sclerosis, often necessitating a tailored distribution channel. The necessity of specialty drug distribution is underscored by the growing demand for personalized medicine and the need for innovative delivery systems that can manage complex logistics and safeguard against potential disruptions. Application-wise, the market supports pharmacies, hospitals, and clinics by providing necessary drugs efficiently and safely, while patients benefit from specialized therapeutic regimens ensuring optimal health outcomes. This distribution model predominantly serves the healthcare sector, influencing both public and private entities.

KEY MARKET STATISTICS
Base Year [2023] USD 4.76 billion
Estimated Year [2024] USD 5.47 billion
Forecast Year [2030] USD 12.25 billion
CAGR (%) 14.44%

Recent market insights point to the burgeoning growth of biologics and gene therapies as primary factors driving market expansion, with innovative technologies like blockchain and IoT enhancing supply chain security and transparency. The emphasis on patient-centric care models expands opportunities for home delivery services and value-based arrangements, providing new avenues for growth. However, challenges such as regulatory complexities, high costs of specialty drugs, and reimbursement issues pose significant obstacles, potentially affecting market dynamics. Limited infrastructure in rural areas may further hinder efficient distribution.

To surmount these challenges, the industry should invest in digital health platforms and data analytics to optimize supply chains and enhance patient engagement. Innovations in cold chain logistics and automation can significantly reduce overhead costs and improve distribution efficacy. The market's nature, characterized by rapid technological advancement and stringent regulatory environments, necessitates a proactive approach in adopting emerging technologies and fostering collaborations between stakeholders. Encouraging innovation in drug formulation and delivery mechanisms, combined with strategic partnerships with tech firms, will bolster the capacity to navigate challenges effectively, ensuring sustainability and competitive advantage in the specialty drug distribution market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Specialty Drug Distribution Market

The Specialty Drug Distribution Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing specialty drug development pipeline and trade
    • Emphasis on drug cost, supply, and storage optimization to offer patient-centric care
  • Market Restraints
    • Complexity in managing different distribution channels
  • Market Opportunities
    • New technology integration and advancements in specialty drug distribution
    • Rising expansion of specialty pharmacies worldwide
  • Market Challenges
    • Changing regulatory frameworks associated with specialty drug handling

Porter's Five Forces: A Strategic Tool for Navigating the Specialty Drug Distribution Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Specialty Drug Distribution Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Specialty Drug Distribution Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Specialty Drug Distribution Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Specialty Drug Distribution Market

A detailed market share analysis in the Specialty Drug Distribution Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Specialty Drug Distribution Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Specialty Drug Distribution Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Specialty Drug Distribution Market, highlighting leading vendors and their innovative profiles. These include Shanghai Pharmaceuticals Group Co., Ltd., CVS Specialty, Inc. by CVS Health Corporation, AmerisourceBergen Corporation, China National Pharmaceutical Group Corporation, Teva Pharmaceutical Industries Ltd., McKesson Corporation, Suzuken Co., Ltd., Eversana, PHOENIX Pharmahandel GmbH & Co KG, Accredo Health Group, Inc., Lifeline Pharmaceuticals, LLC, Aark Pharmaceuticals, Optum, Inc., Feron Healthcare Pvt Ltd., Morris & Dickson Co., LLC, Medipal Holdings Corporation, Kroger Specialty Pharmacy, Walmart Inc., Elevance Health, Inc., FFF Enterprises Inc., Cardinal Health, Inc., Shields Health Solutions Holdings, LLC, Medis Intago, d.o.o., Marken by United Parcel Service, Inc., Centene Corporation, Sun Pharmaceutical Industries Limited, and BioCare, Inc..

Market Segmentation & Coverage

This research report categorizes the Specialty Drug Distribution Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Disease Indication, market is studied across AIDS, Hemophilia, Multiple Sclerosis, Oncology, and Rheumatoid Arthritis.
  • Based on Distributor Type, market is studied across Full line Wholesalers and Specialty Distributors.
  • Based on Distribution Type, market is studied across Hospitals & Clinic Pharmacies, Independent Pharmacies, Large Chain Pharmacies, Mail-Order Pharmacies, Online Stores, and Specialty Pharmacies.
  • Based on End-User, market is studied across Ambulatory Surgical Centers, Healthcare Payers, Home Settings, and Hospital & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing specialty drug development pipeline and trade
      • 5.1.1.2. Emphasis on drug cost, supply, and storage optimization to offer patient-centric care
    • 5.1.2. Restraints
      • 5.1.2.1. Complexity in managing different distribution channels
    • 5.1.3. Opportunities
      • 5.1.3.1. New technology integration and advancements in specialty drug distribution
      • 5.1.3.2. Rising expansion of specialty pharmacies worldwide
    • 5.1.4. Challenges
      • 5.1.4.1. Changing regulatory frameworks associated with specialty drug handling
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Disease Indication: Escalated need of specialty drugs to treat oncology conditions
    • 5.2.2. Distributor Type: Rising presence of full line wholesalers of speciality drugs
    • 5.2.3. Distribution Type: Significant penetration in specialty pharmacies
    • 5.2.4. End-User: Emerging potential for specialty drug distribution in home settings
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Specialty Drug Distribution Market, by Disease Indication

  • 6.1. Introduction
  • 6.2. AIDS
  • 6.3. Hemophilia
  • 6.4. Multiple Sclerosis
  • 6.5. Oncology
  • 6.6. Rheumatoid Arthritis

7. Specialty Drug Distribution Market, by Distributor Type

  • 7.1. Introduction
  • 7.2. Full line Wholesalers
  • 7.3. Specialty Distributors

8. Specialty Drug Distribution Market, by Distribution Type

  • 8.1. Introduction
  • 8.2. Hospitals & Clinic Pharmacies
  • 8.3. Independent Pharmacies
  • 8.4. Large Chain Pharmacies
  • 8.5. Mail-Order Pharmacies
  • 8.6. Online Stores
  • 8.7. Specialty Pharmacies

9. Specialty Drug Distribution Market, by End-User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Centers
  • 9.3. Healthcare Payers
  • 9.4. Home Settings
  • 9.5. Hospital & Clinics

10. Americas Specialty Drug Distribution Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Specialty Drug Distribution Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Specialty Drug Distribution Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. FFF Enterprises Announces its Partnership with Verrica Pharmaceuticals to be the Exclusive Distributor of YCANTH, the First FDA Approved Treatment for Molluscum Contagiosum
    • 13.3.2. Orsini Specialty Pharmacy Selected to be the Exclusive Specialty Pharmacy Partner for VEOPOZ (pozelimab-bbfg), the First and Only Treatment for CHAPLE Disease
    • 13.3.3. Medis and ESTEVE Signed a Distribution Agreement for 10 CEE Countries
    • 13.3.4. Everest Medicines Announces Strategic Partnership with Shanghai Pharma Subsidiary to Accelerate the Commercialization of XERAVA in Mainland China
    • 13.3.5. Elevance Health Announces Closing of BioPlus Acquisition
    • 13.3.6. CVS Health to acquire Oak Street Health
    • 13.3.7. Shields Health Solutions and MyMichigan Health Partner to Enhance Specialty Pharmacy Services for Patients and Families
    • 13.3.8. Shields Health Solutions Expands Nationwide Partnerships to Enhance Specialty Pharmacy Services
    • 13.3.9. Prime Therapeutics Closes USD 1.35 Billion Magellan Rx Acquisition, Uniting Pharmacy and Medical Drug Management Expertise
    • 13.3.10. McKesson Canada Launches New Digital Ecosystem to Simplify and Enhance Specialty Patient Outcomes
    • 13.3.11. Manulife and Shoppers Drug Mart Collaborate to Help Manage Serious Medical Conditions
    • 13.3.12. Marken Reaches Agreement to Acquire the Medical Courier Business of Cedra Express, Expands Direct Presence in New Zealand
    • 13.3.13. Cardinal Health Continues to Expand at-Home Solutions Business
    • 13.3.14. Halozyme to Acquire Antares Pharma for Around USD 960 Million

Companies Mentioned

  • 1. Shanghai Pharmaceuticals Group Co., Ltd.
  • 2. CVS Specialty, Inc. by CVS Health Corporation
  • 3. AmerisourceBergen Corporation
  • 4. China National Pharmaceutical Group Corporation
  • 5. Teva Pharmaceutical Industries Ltd.
  • 6. McKesson Corporation
  • 7. Suzuken Co., Ltd.
  • 8. Eversana
  • 9. PHOENIX Pharmahandel GmbH & Co KG
  • 10. Accredo Health Group, Inc.
  • 11. Lifeline Pharmaceuticals, LLC
  • 12. Aark Pharmaceuticals
  • 13. Optum, Inc.
  • 14. Feron Healthcare Pvt Ltd.
  • 15. Morris & Dickson Co., LLC
  • 16. Medipal Holdings Corporation
  • 17. Kroger Specialty Pharmacy
  • 18. Walmart Inc.
  • 19. Elevance Health, Inc.
  • 20. FFF Enterprises Inc.
  • 21. Cardinal Health, Inc.
  • 22. Shields Health Solutions Holdings, LLC
  • 23. Medis Intago, d.o.o.
  • 24. Marken by United Parcel Service, Inc.
  • 25. Centene Corporation
  • 26. Sun Pharmaceutical Industries Limited
  • 27. BioCare, Inc.

LIST OF FIGURES

  • FIGURE 1. SPECIALTY DRUG DISTRIBUTION MARKET RESEARCH PROCESS
  • FIGURE 2. SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. SPECIALTY DRUG DISTRIBUTION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. SPECIALTY DRUG DISTRIBUTION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SPECIALTY DRUG DISTRIBUTION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SPECIALTY DRUG DISTRIBUTION MARKET DYNAMICS
  • TABLE 7. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY AIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HEMOPHILIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY FULL LINE WHOLESALERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY SPECIALTY DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOSPITALS & CLINIC PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY LARGE CHAIN PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY MAIL-ORDER PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONLINE STORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY SPECIALTY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HEALTHCARE PAYERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOME SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. INDIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. INDIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. INDONESIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. INDONESIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. JAPAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. JAPAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. MALAYSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. MALAYSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. PHILIPPINES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. PHILIPPINES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SINGAPORE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SINGAPORE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH KOREA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. SOUTH KOREA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. TAIWAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. TAIWAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. THAILAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. THAILAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. VIETNAM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. VIETNAM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. DENMARK SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. DENMARK SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. EGYPT SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. EGYPT SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. FINLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. FINLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. FRANCE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. FRANCE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. GERMANY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. GERMANY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. ISRAEL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. ISRAEL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. ITALY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. ITALY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NETHERLANDS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. NETHERLANDS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. NIGERIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. NIGERIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. NORWAY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. NORWAY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. POLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. POLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. QATAR SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. QATAR SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. RUSSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. RUSSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SAUDI ARABIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SAUDI ARABIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SPAIN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SPAIN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. SWEDEN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. SWEDEN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. SWITZERLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. SWITZERLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. TURKEY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. TURKEY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED ARAB EMIRATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED KINGDOM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED KINGDOM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 196. SPECIALTY DRUG DISTRIBUTION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 197. SPECIALTY DRUG DISTRIBUTION MARKET, FPNV POSITIONING MATRIX, 2023